Israel’s AccessFintech and Noble get VC cheques; MediWound raises $30 mn

 Israel’s AccessFintech and Noble get VC cheques; MediWound raises $30 mn

Israel-based AccessFintech has completed a $60-million Series C funding round led by WestCap.

WestCap was joined in the round by BNY Mellon and Bank of America. AccessFintech’s Series B investors Dawn Capital, J.P. Morgan, Goldman Sachs and Citigroup also joined the round.

With the completion of its Series C round, AccessFintech has now raised $97 million since 2018. This includes $20 million in the Series B round.

The startup was founded in 2015 by Roy Saadon and Steve Fazio.  The duo had earlier founded Triana Software, which they had sold for $247 million in 2007 to the British ICAP Group.


Israel-based biopharmaceutical firm MediWound has raised $30 million from investors including New Era Capital Partners, Deep Insight, IBF, and Discount Capital.

The Nasdaq-listed company has developed and sells a preparation for treating burns that is undergoing clinical trials.

The company’s share price has slumped 51% over the last year, and it commands a market capitalization of $58 million.

Ofer Gonen, who was earlier the CEO of Clal Biotechnology, was recently appointed CEO of MediWound. Clal Biotechnology holds a 33% stake in the company.


Israeli no-code fintech startup Noble has raised $18 million in a Series A funding round from a bunch of marquee investors led by Insight Partners.

The other investors that backed the fintech include Cross River Digital Ventures, Y Combinator, Flexport Fund, TLV Partners, Operator Partners, Verissimo Ventures, Interplay Ventures, Plug and Play, and the George Kaiser Family Foundation.

Noble says its platform helps companies manage the entire underwriting flows end-to-end without building APIs integrated into their offerings.

The company was founded in 2021 by chief executive officer Tomer Biger and chief technology officer Moran Mishan.

Aman Malik

error: Content is protected !!
The Capital Quest